Effect of an Investigational Multi-Purpose Solution on Lens Moisture
Study Details
Study Description
Brief Summary
The purpose of the study is to evaluate the effect of an investigational multi-purpose disinfecting solution (MPDS) compared to a marketed multi-purpose solution on the moisture of silicone hydrogel contact lenses.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: FID 114675A Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses |
Device: FID 114675A Multi-Purpose Disinfecting Solution (MPDS)
Investigational solution intended for use as a cleaning, rinsing, reconditioning, disinfecting, and storage solution for silicone hydrogel and soft contact lenses
Device: Silicone Hydrogel Contact Lenses
Commercially marketed silicone hydrogel contact lenses per habitual prescription for daily wear use, at least 8 hours/day. New pair dispensed at Day 0 (Baseline Visit) and at the conclusion of Day 1 (Visit 2).
Other Names:
|
Active Comparator: ReNu MultiPlus Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses |
Device: ReNu Fresh Lens Comfort Multi-Purpose Solution (MPS)
Commercially marketed prodouct indicated for cleaning, removing protein deposits, rinsing, disinfecting, and storing soft contact lenses
Other Names:
Device: Silicone Hydrogel Contact Lenses
Commercially marketed silicone hydrogel contact lenses per habitual prescription for daily wear use, at least 8 hours/day. New pair dispensed at Day 0 (Baseline Visit) and at the conclusion of Day 1 (Visit 2).
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Mean Ex-Vivo Advancing Contact Angle [Day 1, 8 hours]
Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.
- Mean Ex-Vivo Advancing Contact Angle [Day 8, 16 hours]
Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 years of age or older.
-
Wears silicone hydrogel contact lenses on a daily wear basis i.e. disinfects lenses every night).
-
Has successfully worn contact lenses for 5 days, 8 hours per day, prior to baseline visit.
-
Vision is correctable to 20/30 or better in each eye at distance with study lenses at baseline visit.
-
Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
-
Known sensitivity or intolerance to contact lens multi-purpose solutions.
-
Use of any topical ocular OTC or prescribed topical ocular medications.
-
History or current ocular infections or ocular inflammatory events.
-
Ocular surgery within the past year.
-
Medical condition or use of medication that cause ocular side effects.
-
Participation in any investigational study within the past 30 days.
-
Other protocol-defined exclusion criteria may apply.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Contact Alcon Call Center for Trial Locations | Fort Worth | Texas | United States | 76134 |
Sponsors and Collaborators
- Alcon Research
Investigators
- Study Director: Justin R Webb, OD, Alcon Research
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- C-09-031
Study Results
Participant Flow
Recruitment Details | Participants were recruited from 1 US study center. |
---|---|
Pre-assignment Detail |
Arm/Group Title | FID 114675A | ReNu MultiPlus |
---|---|---|
Arm/Group Description | Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses | Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses |
Period Title: Overall Study | ||
STARTED | 35 | 33 |
COMPLETED | 32 | 32 |
NOT COMPLETED | 3 | 1 |
Baseline Characteristics
Arm/Group Title | FID 114675A | ReNu MultiPlus | Total |
---|---|---|---|
Arm/Group Description | Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses | Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses | Total of all reporting groups |
Overall Participants | 35 | 33 | 68 |
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
43.9
(9.2)
|
42.8
(11.2)
|
43.4
(10.2)
|
Sex: Female, Male (Count of Participants) | |||
Female |
23
65.7%
|
22
66.7%
|
45
66.2%
|
Male |
12
34.3%
|
11
33.3%
|
23
33.8%
|
Region of Enrollment (participants) [Number] | |||
United States |
35
100%
|
33
100%
|
68
100%
|
Outcome Measures
Title | Mean Ex-Vivo Advancing Contact Angle |
---|---|
Description | Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens. |
Time Frame | Day 1, 8 hours |
Outcome Measure Data
Analysis Population Description |
---|
Intent to Treat. |
Arm/Group Title | FID 114675A | ReNu MultiPlus |
---|---|---|
Arm/Group Description | Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses | Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses |
Measure Participants | 34 | 32 |
Mean (Standard Deviation) [Degrees] |
56.7
(21.2)
|
59.2
(23.7)
|
Title | Mean Ex-Vivo Advancing Contact Angle |
---|---|
Description | Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens. |
Time Frame | Day 8, 16 hours |
Outcome Measure Data
Analysis Population Description |
---|
Intent to treat. |
Arm/Group Title | FID 114675A | ReNu MultiPlus |
---|---|---|
Arm/Group Description | Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses | Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses |
Measure Participants | 31 | 32 |
Mean (Standard Deviation) [Degrees] |
59.5
(21.2)
|
63.4
(17.5)
|
Adverse Events
Time Frame | Adverse events were collected for the duration of the study: 23 Nov 2009 to 27 Jan 2010. | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | FID 114675A | ReNu MultiPlus | ||
Arm/Group Description | Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses | Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses | ||
All Cause Mortality |
||||
FID 114675A | ReNu MultiPlus | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
FID 114675A | ReNu MultiPlus | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/35 (0%) | 0/33 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
FID 114675A | ReNu MultiPlus | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/35 (0%) | 0/33 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Director of Alcon Clinical |
---|---|
Organization | Alcon Research, Ltd. |
Phone | 1-888-451-3937 |
medinfo@alconlabs.com |
- C-09-031